“Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study” (2024) Dermatology Practical & Conceptual, 14(4), p. e2024250. doi:10.5826/dpc.1404a250.